Ignite Creation Date:
2025-12-24 @ 12:20 PM
Ignite Modification Date:
2025-12-27 @ 9:59 PM
Study NCT ID:
NCT00393861
Status:
COMPLETED
Last Update Posted:
2016-03-24
First Post:
2006-10-26
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Oxaliplatin Plus Bevacizumab in Germ Cell Tumor Patients
Sponsor:
Indiana University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
0609-11; IUCRO-0166
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |